These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 25170641)

  • 21. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
    Niazi T; Elakshar S; Stroian G
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
    Riesterer O
    Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer.
    Westover KD; Iyengar P; Sharma AN; Timmerman R
    Lung Cancer; 2015 Aug; 89(2):87-93. PubMed ID: 26028304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiotherapy for pulmonary metastases.
    Chmura SJ; Salama JK; Weichselbaum RR
    Semin Thorac Cardiovasc Surg; 2013; 25(4):292-9. PubMed ID: 24673958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is stereotactic radiotherapy equivalent to metastasectomy in patients with pulmonary oligometastases?
    Li S; Nie S; Li Z; Che G
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):544-550. PubMed ID: 31180484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
    Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Mason D; Murthy S; Rice TW; Mazzone P; Machuzak M; Mekhail T; Videtic GM
    J Thorac Oncol; 2009 Aug; 4(8):976-82. PubMed ID: 19633473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic body radiation therapy for oligometastases.
    Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
    Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiotherapy for oligometastases.
    Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
    Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II).
    Siva S; Kron T; Bressel M; Haas M; Mai T; Vinod S; Sasso G; Wong W; Le H; Eade T; Hardcastle N; Chesson B; Pham D; Høyer M; Montgomery R; Ball D
    BMC Cancer; 2016 Mar; 16():183. PubMed ID: 26944262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in local and ablative treatment of oligometastasis in prostate cancer.
    Yao HH; Hong MKh; Corcoran NM; Siva S; Foroudi F
    Asia Pac J Clin Oncol; 2014 Dec; 10(4):308-21. PubMed ID: 25155557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
    Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic ablative radiation therapy for primary lung tumors.
    Heinzerling JH; Kavanagh B; Timmerman RD
    Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.
    Milano MT; Katz AW; Schell MC; Philip A; Okunieff P
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1516-22. PubMed ID: 18495378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.
    Yamashita H; Niibe Y; Yamamoto T; Katsui K; Jingu K; Kanazawa S; Terahara A; Nakagawa K
    Jpn J Clin Oncol; 2016 Jul; 46(7):687-91. PubMed ID: 27162324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer.
    Filippi AR; Guerrera F; Badellino S; Ceccarelli M; Castiglione A; Guarneri A; Spadi R; Racca P; Ciccone G; Ricardi U; Ruffini E
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):505-12. PubMed ID: 26899780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer.
    Shultz DB; Diehn M; Loo BW
    Semin Radiat Oncol; 2015 Apr; 25(2):78-86. PubMed ID: 25771411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligometastases: history of a hypothesis.
    Milano MT; Biswas T; Simone CB; Lo SS
    Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
    Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
    Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.